Golpanian, Rachel Shireen
Yosipovitch, Gil
Levy, Cynthia
Article History
Received: 28 April 2020
Accepted: 3 June 2020
First Online: 18 June 2020
Compliance with Ethical Standards
:
: CL received consulting fees from CymaBay, Genfit, Pliant, Shire, GSK, Mirum, TARGET PharmaSolutions and Cara Therapeutics, research grants from CymaBay, Intercept, Genfit, Shire, GSK, Cara Therapeutics, TARGET PharmaSolutions, Novartis, Durect, Enanta, Genkyotex, Gilead, Alnylam, and Mitsubishi. CL is an associate editor for Liver Transplantation, committee participant at ABIM and receives royalties from Up-to-Date. GY reports grants and personal fees from Sanofi Regeneron, personal fees from TREVI, grants and personal fees from Pfizer, personal fees from Galderma, grants from Sun Pharma, grants and personal fees from Kiniksa, grants and personal fees from Menlo, personal fees from Eli Lily, grants and personal fees from Novartis, personal fees from Bellus, grants and personal fees from Leo, outside the submitted work. RSG has no conflicts of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.